How should therapeutic information be transferred to users?-Reference-Cited by-同舟云学术

How should therapeutic information be transferred to users?

Published:2003-08 Issue:4 Volume:17 Page:495-503
ISSN:0767-3981
Container-title:Fundamental and Clinical Pharmacology
language:en
Short-container-title:Fundam Clin Pharmacol

Author:

Boissel Jean-Pierre,Haugh Margaret,Fardeheb Malik,Nony Patrice,Gueyffier Francois,Strang Nigel

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1472-8206.2003.00161.x/fullpdf

Reference70 articles.

1. Impact of randomized clinical trials on medical practices

2. 3J.P. Boissel, on behalf of the Validata Group, Goor J. Noothoven van, and J.P. Christensen , in: (Eds), Advances in Medical Informatics , IOS Pressedn1992 ; The Validata Group: a computerized system to deliver validated information to prescribers. pp. 349 -357 .

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Le courtage des connaissances en thérapeutique. Une étude pilote de faisabilité;Pratiques et Organisation des Soins;2010-03-01

2. Building capacity for antiretroviral delivery in South Africa: A qualitative evaluation of the PALSA PLUS nurse training programme;BMC Health Services Research;2008-11-18

3. Networkcentric healthcare and bioinformatics: Unified operations within three domains of knowledge;Expert Systems with Applications;2006-01

4. How to measure non-consistency of medical practices with available evidence in therapeutics: a methodological framework;Fundamental and Clinical Pharmacology;2005-10

5. Bridging the gap between therapeutic research results and physician prescribing decisions: knowledge transfer, a prerequisite to knowledge translation;European Journal of Clinical Pharmacology;2004-09-16